JP2007505083A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505083A5 JP2007505083A5 JP2006525827A JP2006525827A JP2007505083A5 JP 2007505083 A5 JP2007505083 A5 JP 2007505083A5 JP 2006525827 A JP2006525827 A JP 2006525827A JP 2006525827 A JP2006525827 A JP 2006525827A JP 2007505083 A5 JP2007505083 A5 JP 2007505083A5
- Authority
- JP
- Japan
- Prior art keywords
- benzothiazol
- acetonitrile
- pyrimidin
- amino
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102740.2 | 2003-09-12 | ||
| EP03102740 | 2003-09-12 | ||
| PCT/EP2004/052090 WO2005025567A1 (en) | 2003-09-12 | 2004-09-08 | Benzothiazole derivatives for the treatment of diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007505083A JP2007505083A (ja) | 2007-03-08 |
| JP2007505083A5 true JP2007505083A5 (https=) | 2007-10-25 |
| JP5021307B2 JP5021307B2 (ja) | 2012-09-05 |
Family
ID=34306921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525827A Expired - Fee Related JP5021307B2 (ja) | 2003-09-12 | 2004-09-08 | 糖尿病治療のためのベンゾチアゾール誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20070088017A1 (https=) |
| EP (1) | EP1696909B1 (https=) |
| JP (1) | JP5021307B2 (https=) |
| AT (1) | ATE378047T1 (https=) |
| AU (1) | AU2004271740B2 (https=) |
| CA (1) | CA2534314C (https=) |
| CY (1) | CY1107820T1 (https=) |
| DE (1) | DE602004010178T2 (https=) |
| DK (1) | DK1696909T3 (https=) |
| ES (1) | ES2297494T3 (https=) |
| HR (1) | HRP20070527T3 (https=) |
| IL (1) | IL174250A (https=) |
| NO (1) | NO20061600L (https=) |
| PL (1) | PL1696909T3 (https=) |
| PT (1) | PT1696909E (https=) |
| SI (1) | SI1696909T1 (https=) |
| WO (1) | WO2005025567A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838522B2 (en) * | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
| KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 ｊｎｋ 억제제 |
| BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| CN101528214B (zh) | 2006-08-24 | 2013-06-05 | 田纳西大学研究基金会 | 取代的n-酰基苯胺及其使用方法 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100121057A1 (en) * | 2007-04-17 | 2010-05-13 | Merck Serono Sa | Process for the Preparation of Piperazine Benzothiazoles |
| UA100527C2 (en) * | 2007-10-10 | 2013-01-10 | Астразенека Аб | Benzothiazoles as ghrelin receptor modulators |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
| PT2872482T (pt) | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
| US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| WO2014114186A1 (zh) * | 2013-01-24 | 2014-07-31 | 山东亨利医药科技有限责任公司 | Jnk抑制剂 |
| WO2017025980A2 (en) * | 2015-08-12 | 2017-02-16 | Shoolineuniversity Of Biotechnology And Management Sciences | Novel benzothiazole derivatives with enhanced biological activity |
| CN115887434B (zh) * | 2022-11-23 | 2024-12-24 | 四川大学 | 具有抗氧化作用的药物用于制备治疗多囊卵巢综合征药物的用途 |
| US11905260B1 (en) | 2023-10-13 | 2024-02-20 | King Faisal University | N′-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound |
| US11970467B1 (en) | 2023-10-13 | 2024-04-30 | King Faisal University | N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1176269A (en) * | 1981-03-02 | 1984-10-16 | Kazimir Sestanj | N-naphthoylglycine derivatives |
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6559188B1 (en) * | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
| EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
| ATE340572T1 (de) * | 2001-12-07 | 2006-10-15 | Applied Research Systems | Benzazole derivate zur behandlung von scleroderma |
| WO2003091249A1 (en) * | 2002-04-25 | 2003-11-06 | Applied Research Systems Ars Holding N.V. | Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders |
-
2004
- 2004-09-08 JP JP2006525827A patent/JP5021307B2/ja not_active Expired - Fee Related
- 2004-09-08 AU AU2004271740A patent/AU2004271740B2/en not_active Ceased
- 2004-09-08 WO PCT/EP2004/052090 patent/WO2005025567A1/en not_active Ceased
- 2004-09-08 EP EP04787110A patent/EP1696909B1/en not_active Expired - Lifetime
- 2004-09-08 ES ES04787110T patent/ES2297494T3/es not_active Expired - Lifetime
- 2004-09-08 SI SI200430550T patent/SI1696909T1/sl unknown
- 2004-09-08 HR HR20070527T patent/HRP20070527T3/xx unknown
- 2004-09-08 PT PT04787110T patent/PT1696909E/pt unknown
- 2004-09-08 US US10/571,291 patent/US20070088017A1/en not_active Abandoned
- 2004-09-08 PL PL04787110T patent/PL1696909T3/pl unknown
- 2004-09-08 DE DE602004010178T patent/DE602004010178T2/de not_active Expired - Lifetime
- 2004-09-08 CA CA2534314A patent/CA2534314C/en not_active Expired - Fee Related
- 2004-09-08 AT AT04787110T patent/ATE378047T1/de active
- 2004-09-08 DK DK04787110T patent/DK1696909T3/da active
-
2006
- 2006-03-12 IL IL174250A patent/IL174250A/en not_active IP Right Cessation
- 2006-04-07 NO NO20061600A patent/NO20061600L/no not_active Application Discontinuation
-
2007
- 2007-12-04 CY CY20071101543T patent/CY1107820T1/el unknown
-
2013
- 2013-10-08 US US14/048,690 patent/US20140107116A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007505083A5 (https=) | ||
| JP5021307B2 (ja) | 糖尿病治療のためのベンゾチアゾール誘導体 | |
| CA2394809A1 (en) | Benzazole derivatives and their use as jnk modulators | |
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| RU2008135690A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| RU2007100136A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| ZA200105055B (en) | Method of using cyclooxygenase-2-inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia. | |
| RU2006144811A (ru) | Новые цис-имидазолины | |
| HUP0202399A2 (hu) | Dopamin D3 receptor ligandumok alkalmazása veseelégtelenség kezelésére szolgáló gyógyszerek előállítására | |
| JP2014523400A5 (https=) | ||
| EP2455080A1 (en) | S1P1 receptor agonists for use in the treatment of multiple sclerosis | |
| US20170065608A1 (en) | Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome | |
| US7432254B2 (en) | Method for treating glaucoma IC | |
| JP2007505085A5 (https=) | ||
| US20050119277A1 (en) | Benzazole derivatives for the treatment of scleroderma | |
| US20070185104A1 (en) | Benzoxazole acetonitriles | |
| US20020183365A1 (en) | Method for treating fibrotic diseases or other indications IIIC | |
| JP2002506069A5 (https=) | ||
| US8658640B2 (en) | JNK inhibitors for the treatment of endometriosis | |
| JPWO2020210707A5 (https=) | ||
| US8592414B2 (en) | JNK inhibitors for the treatment of endometriosis | |
| WO2021182596A1 (ja) | 上眼瞼溝深化改善剤 | |
| WO2003090750A1 (en) | Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera | |
| JPWO2023002011A5 (https=) | ||
| WO2002053162A1 (en) | Method for treating glaucoma iiib |